Moris Farhi: Difference between revisions
(Expanded; changed category) |
(fix tense (as he's still alive)) |
||
| Line 1: | Line 1: | ||
{{real world}} | {{real world}} | ||
'''Moris Farhi''' | '''Moris Farhi''' is a British writer and actor who, in [[1964]], submitted scripts for two ''Doctor Who'' stories, ''[[Farewell Great Macedon]]'' and ''[[The Fragile Yellow Arc of Fragrance]]''. Neither story was produced, but both were published in [[2009]] by [[Nothing at the End of the Lane (publisher)|Nothing at the End of the Lane]]. | ||
Farhi, who is of Turkish descent, alternated between writing and acting, appearing in two [[James Bond]] films, ''From Russia with Love'' and ''You Only Live Twice''. He also wrote the 1962 film ''The Primitives''. In early 1964, [[David Whitaker]], who was beginning to compile prospective storylines for ''Doctor Who'', invited Farhi to submit some scripts. | Farhi, who is of Turkish descent, alternated between writing and acting, appearing in two [[James Bond]] films, ''From Russia with Love'' and ''You Only Live Twice''. He also wrote the 1962 film ''The Primitives''. In early 1964, [[David Whitaker]], who was beginning to compile prospective storylines for ''Doctor Who'', invited Farhi to submit some scripts. | ||
Revision as of 12:44, 13 October 2009
Moris Farhi is a British writer and actor who, in 1964, submitted scripts for two Doctor Who stories, Farewell Great Macedon and The Fragile Yellow Arc of Fragrance. Neither story was produced, but both were published in 2009 by Nothing at the End of the Lane.
Farhi, who is of Turkish descent, alternated between writing and acting, appearing in two James Bond films, From Russia with Love and You Only Live Twice. He also wrote the 1962 film The Primitives. In early 1964, David Whitaker, who was beginning to compile prospective storylines for Doctor Who, invited Farhi to submit some scripts.
Farhi also submitted an unproduced script for another cult favourite, The Prisoner. His script for that series, The Outsider, was published in the mid-2000s.
